Alzamend Neuro, Inc.
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, wh…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Alzamend Neuro, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Alzamend Neuro, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Alzamend Neuro, Inc..